tomeko

Myeloid neoplasm associated with FGFR1 rearrangement

Just diagnosed with Myeloid neoplasm associated with FGFR1 rearrangement?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Myeloid neoplasm associated with FGFR1 rearrangement, look for clinical trials, and connect with others living with it — all in one place.

Open the full Myeloid neoplasm associated with FGFR1 rearrangement hub →

Overview

Myeloid neoplasm associated with FGFR1 rearrangement is a rare condition. Also known as 8p11 myeloproliferative syndrome, Stem cell leukemia/lymphoma. Tomeko brings together the specialists, research, clinical trials, treatments and community for Myeloid neoplasm associated with FGFR1 rearrangement so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:168953 · OMIM 613523 · ICD-10 C92.7 · GARD 0017043

Find care for Myeloid neoplasm associated with FGFR1 rearrangement

Authoritative references for Myeloid neoplasm associated with FGFR1 rearrangement

Common questions

I was just diagnosed with Myeloid neoplasm associated with FGFR1 rearrangement — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Myeloid neoplasm associated with FGFR1 rearrangement, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Myeloid neoplasm associated with FGFR1 rearrangement?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Myeloid neoplasm associated with FGFR1 rearrangement, filtered to your area.

Are there clinical trials for Myeloid neoplasm associated with FGFR1 rearrangement?

Tomeko shows live, recruiting studies for Myeloid neoplasm associated with FGFR1 rearrangement from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com